Fig. 1From: Pemafibrate decreases triglycerides and small, dense LDL, but increases LDL-C depending on baseline triglycerides and LDL-C in type 2 diabetes patients with hypertriglyceridemia: an observational studyProfile of LDL-C between groups before and after pemafibrate administration. Median and IQR of LDL-C in group I are shown in red boxplots and those in group NI are shown in black boxplotsBack to article page